Clinical Trial Update: H-1337 Ophthalmic Solution Phase 1/2 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of H-1337 ophthalmic solution for glaucoma (open-angle) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• H-1337 ophthalmic solution (H-1337 ophthalmic solution)

Snippet

Sponsor: Allysta Pharmaceutical | Conditions: Glaucoma, Open-Angle | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-08-02